Plasmonic cell mass accumulation profiling platform for determining therapeutic response of cancer cells
AssigneeIzmir Biyotip Ve Genom Merkezi
InventorArif Engin CETIN
Life of this patent
Estimating the term…
Abstract
A plasmonic-based biosensor platform that determines the biophysical properties of cells, the changes within, and their therapeutic behavior upon the molecules that cause these changes in an ex vivo and label-free manner is provided. The plasmonic-based biosensor platform includes a plasmonic chip, a light source, an inverted microscope, an incubator case, an optical read-out device, and a graphical user interface. The biosensor platform of the invention could determine the therapeutic susceptibility of cancer cells to cancer drugs in a label-free manner.
Claims12
A plasmonic-based biosensor platform for detecting biophysical properties of cells and changes within, as well as a therapeutic response of the cells against molecules causing the changes in a label-free and ex vivo fashion, comprising:
- a plasmonic chip consisting of a periodic nanohole array fabricated on a nm-thick metal film and a surface where the cells to be examined are seeded,
- a light source illuminating the plasmonic chip,
- an inverted microscope used to illuminate the plasmonic chip to collect a light transmitted from the plasmonic chip and to send the light to an optical read-out device,
- an incubator case providing incubator conditions for a cell culture and integrated to the inverted microscope,
- the optical read-out device measuring a transmission response of the plasmonic chip and integrated to the inverted microscope,
- a graphical user interface with algorithms controlling the optical read-out device and converting outputs of the optical read-out device into meaningful MAR information.
Dependencies are inferred from the claim text.